BR0109802A - Preparações farmacêuticas e sua fabricação - Google Patents

Preparações farmacêuticas e sua fabricação

Info

Publication number
BR0109802A
BR0109802A BR0109802-0A BR0109802A BR0109802A BR 0109802 A BR0109802 A BR 0109802A BR 0109802 A BR0109802 A BR 0109802A BR 0109802 A BR0109802 A BR 0109802A
Authority
BR
Brazil
Prior art keywords
emulsion
pharmaceutical preparations
particles
active substance
manufacture
Prior art date
Application number
BR0109802-0A
Other languages
English (en)
Inventor
John Nicholas Staniforth
Michael John Tobyn
Cheryl Julia Clinch
Robert Price
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0109802(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of BR0109802A publication Critical patent/BR0109802A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"PREPARAçõES FARMACêUTICAS E SUA FABRICAçãO". Um método para preparar uma composição compreendendo partículas ativas, que compreendem uma substância ativa, compreende as etapas de a) proporcionar uma emulsão tendo uma fase dispersa compreendendo uma solução da substância ativa em um solvente e b) induzir a formação, na emulsão, de partículas sólidas compreendendo a substância ativa. As partículas podem ser isoladas da emulsão. São proporcionadas partículas ativas tendo uma curtose normalizada de pelo menos 5 e um diâmetro médio de menos do que 100 <109>m.
BR0109802-0A 2000-04-05 2001-04-05 Preparações farmacêuticas e sua fabricação BR0109802A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008411.1A GB0008411D0 (en) 2000-04-05 2000-04-05 Pharmaceutical preparations and their manufacture
PCT/GB2001/001562 WO2001074332A1 (en) 2000-04-05 2001-04-05 Pharmaceutical preparations and their manufacture

Publications (1)

Publication Number Publication Date
BR0109802A true BR0109802A (pt) 2003-01-21

Family

ID=9889294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109802-0A BR0109802A (pt) 2000-04-05 2001-04-05 Preparações farmacêuticas e sua fabricação

Country Status (22)

Country Link
US (2) US20030157182A1 (pt)
EP (1) EP1267833B1 (pt)
JP (1) JP2003528907A (pt)
KR (1) KR20030011816A (pt)
CN (1) CN1420764A (pt)
AT (1) ATE269057T1 (pt)
AU (1) AU4440601A (pt)
BR (1) BR0109802A (pt)
CA (1) CA2404367A1 (pt)
DE (1) DE60103865T2 (pt)
DK (1) DK1267833T3 (pt)
ES (1) ES2218402T3 (pt)
GB (1) GB0008411D0 (pt)
HU (1) HUP0300334A3 (pt)
IL (1) IL152074A0 (pt)
MX (1) MXPA02009797A (pt)
NO (1) NO20024737L (pt)
PL (1) PL357808A1 (pt)
PT (1) PT1267833E (pt)
TR (1) TR200401567T4 (pt)
WO (1) WO2001074332A1 (pt)
ZA (1) ZA200207508B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109890225A (zh) * 2016-11-10 2019-06-14 日本烟草产业株式会社 球状的粉末凝聚体及其制造方法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073827A1 (en) * 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
JP5243247B2 (ja) * 2005-07-28 2013-07-24 アイエスピー インヴェストメンツ インコーポレイテッド スプレー乾燥された粉体及び粒状化された材料の特性の改良方法、並びにそれによって製造した製品
JP2007326083A (ja) * 2006-06-09 2007-12-20 Fujifilm Corp 固体微粒子及びその製造方法
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
CN101541415B (zh) * 2006-11-14 2012-08-22 巴斯夫欧洲公司 生产亚微核/壳粒子的微悬浮乳液或悬浮液的方法
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
EP2125938A2 (en) * 2007-01-26 2009-12-02 Isp Investments Inc. Formulation process method to produce spray dried products
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
PL220269B1 (pl) 2008-04-21 2015-09-30 Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego
MX2011000410A (es) 2008-07-18 2011-03-24 Prosonix Ltd Proceso para mejorar la cristalinidad de particulas de fluticasona.
CN102107127B (zh) * 2011-01-11 2015-04-22 西安蓝晓科技新材料股份有限公司 一种粉体造粒技术
EP2731627A4 (en) * 2011-07-15 2015-06-17 Eupharma Pty Ltd ORAL COMPOSITIONS WITH ANTAZID, ANESTHETIC AND INORGANIC MATRIX WITH SILICON DIOXIDE AND TITANIUM DIOXIDE
PT107433B (pt) * 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
EP1649850A1 (en) * 1993-11-19 2006-04-26 Alkermes Controlled Therapeutics Inc. II Preparation of biodegradable microparticles containing a biologically active agent
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
DE19617085A1 (de) * 1996-04-29 1997-10-30 Bayer Ag Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6150505A (en) 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109890225A (zh) * 2016-11-10 2019-06-14 日本烟草产业株式会社 球状的粉末凝聚体及其制造方法

Also Published As

Publication number Publication date
US20030157182A1 (en) 2003-08-21
AU4440601A (en) 2001-10-15
EP1267833A1 (en) 2003-01-02
GB0008411D0 (en) 2000-05-24
PT1267833E (pt) 2004-11-30
NO20024737D0 (no) 2002-10-02
CN1420764A (zh) 2003-05-28
TR200401567T4 (tr) 2004-08-23
PL357808A1 (en) 2004-07-26
ATE269057T1 (de) 2004-07-15
IL152074A0 (en) 2003-05-29
DE60103865D1 (de) 2004-07-22
DE60103865T2 (de) 2004-10-28
ZA200207508B (en) 2003-09-19
DK1267833T3 (da) 2004-07-19
HUP0300334A2 (hu) 2003-09-29
US20100015234A1 (en) 2010-01-21
EP1267833B1 (en) 2004-06-16
CA2404367A1 (en) 2001-10-11
JP2003528907A (ja) 2003-09-30
KR20030011816A (ko) 2003-02-11
NO20024737L (no) 2002-11-18
ES2218402T3 (es) 2004-11-16
WO2001074332A1 (en) 2001-10-11
MXPA02009797A (es) 2004-09-13
HUP0300334A3 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
BR0109802A (pt) Preparações farmacêuticas e sua fabricação
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
CA2330330A1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
NO971965D0 (no) Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav
NO20005431D0 (no) Gelérbare farmasøytiske preparater
ATE464885T1 (de) Verfahern zur herstellung von festen verabreichungssystemen für eingekapselte und nicht-eingekapselte pharmazeutische wirkstoffe
BR0010354A (pt) Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção
BR9809328A (pt) Processo para preparação de formas sólidas de medicamentos empregáveis peroralmente com desprendimento controlado de substância ativa
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ATE269080T1 (de) Mikrokapsel mit verzögerter freigabe für wasserlösliche arzneistoffe
AU4655699A (en) Solid dispersed preparation of poorly water-soluble drug containing oil, fatty acid or mixtures thereof
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
BR0115144A (pt) Partìculas
BR0107899A (pt) Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida
ATE297223T1 (de) Teilchenförmige vitaminzubereitung
PT1014947E (pt) Metodo de preparacao de composicoes farmaceuticas de particulas lipidicas compreendendo um agente lipidico e uma proteina
CO4410175A1 (es) Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion
DE60218744D1 (de) Partikuläre zusammensetzung enthaltend eine lipophile flüssigkeit
BRPI0307319B8 (pt) forma de dosagem oral para liberação controlada de droga e processo para sua preparação
AR034777A1 (es) Preparaciones farmaceuticas que contienen resinas de intercambio de iones cargadas con substancia activa
CO4970742A1 (es) Suspension farmaceutica que comprende hemihidrato de nevipa- rina
WO1999043299A3 (en) Oral formulation for hydrophilic drugs
ES2188670T3 (es) Formulaciones que contienen codeina.
DE69830997D1 (de) Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten
BR9611262A (pt) Meios de partìculas avançados para separação precisa de partìculas suspensas em fluidos

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: VECTURA LIMITED (GB)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060042098/RJ DE 27/03/2006.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.